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To test our hypothesis that specific interactions of ACTH peptides with model ipid membranes reflect he 
biological importance of similar interactions on target cells, we investigated the liposome-mediated 
labeling of ACTH fragments with the extremely hydrophobic photolabel, 3-trifluoromethyl-3-(m- 
[1251]iodophenyl)diairine. Correlations were found between the labeling rates and the agonistic and 
antagonistic potencies of the peptides for in vitro steroidogenesis and inhibition of a synaptosomal protein 
kinase. A model for the cross-reactivity between ACTH and opioid peptides is discussed. 
Peptide hormone-lipid membrane interaction Hydrophobic photolabeling Adrenocorticotropin 
Dynorphin Enkephalin 
1. INTRODUCTION 
Adrenocorticotropin-( 1-24)-tetracosapeptide 
(ACTHr_24) is a very potent, synthetic fragment of 
the native hormone, ACTHr-39. It induces 
steroidogenesis n adrenal cells (review [l]) and in- 
hibits the phosphorylation of synaptosomal pro- 
teins [2]. ACTH also produces pharmacologic ef- 
fects previously thought to be specific for opioid 
peptides and alkaloids [3-51. Structure-activity 
relationships of ACTH are established in some 
detail [1,2]. At least two functionally different se- 
quences of adjacent amino acids can be 
distinguished: the N-terminal message comprising 
amino acids l-10 contains the information for 
triggering the responses, and the C-terminal 
Abbreviations: ACTH, adrenocorticotropic hormone; 
fragments of peptides, designated by subscript 
numerals, e.g. ACTHr-lo, adrenocorticotropin-(l-10) 
decapcptide; dynorphinr-13, dynorphin-(1-13)-trideca- 
peptide; amino acids, according to the IUPAC-IUP 
recommendations; PA, dipalmitoylphosphatidic acid; 
PC, egg yolk lecithin, phosphatidylcholine; [“‘I]TID, 
3-trifluoromethyl-(m-[‘2sI]iodophenyl)diazirine 
Endorphin Liposome 
address (1 l-24) adds specific receptor affinity and 
potentiates the message. Shortening of the message 
segment leads to weak agonists (ACTHs-u), par- 
tial agonists (ACTHa-&, and finally to com- 
petitive antagonists (ACTHr-24, ACTHrr-~4). 
The lipid phase of the target cell membranes is 
thought to regulate the intrinsic affinity of recep- 
tors for the peptides [6]. However, it may also 
serve to facilitate receptor binding by specific, 
direct reaction with the agonists and antagonists 
[7]. Thus, we found that ACTHr-24 is adsorbed to 
pure lipid membranes [8,9] and that the address re- 
mains on the surface in an extended conformation, 
whereas the message nters the membrane perpen- 
dicularly as a helix, establishing contacts with the 
hydrophobic layer [7,10,11]. For determining the 
structure and head-group specificity of such in- 
teractions, the extremely hydrophobic photolabel, 
3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine 
([‘251]TID) of Brunner and Semenza [12] was used 
to label those parts of a peptide that penetrate into 
the hydrophobic layer of model membranes. In 
this work, we estimated the liposome-mediated 
labeling rate of ACTH peptides (which is a 
measure for their amphiphilicity or ease of mem- 
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brane penetration) and compared it with their 
biological potency. Furthermore, the molecular 
anatomy and the ~p~philicity of ACTH pep- 
tides, d~orp~n, ~~ndo~~n, and leuenkeph~in 
are discussed with regard to their biological cross- 
reactivity. 
We concluded that model membranes are sen- 
sitive probes for the amphiphilic and conforma- 
tional requirements necessary for biological activi- 
ty and that, indeed, the specific interactions of 
peptides with model membranes may reflect the 
biological importance of analogous interactions 
with the lipid phase of the target cell membranes. 
Such interactions may serve to facilitate the proper 
interaction between peptides and their receptors. 
2. MATERIALS AND METHODS 
Dynorphini-Is, cu-melanotropin ((u-MSH), and 
leuenkephalin were purchased from Bachem 
(Bubendorf). ACTHr-IO, ACTHI-+, ACTHI-I:, 
amide, ACTH+~4, ACTH,_~4, and ACTHrl-~4 
were prepared by known procedures [11, [1251]TID, 
was synthesized as in [12] and had spec. act. 3.7 x 
10” Bq/mmol. Egg yolk lecithin ~hosphatidyl- 
choline, PC) was isolated according to f 131. Dipal- 
mitoylphosphatidic acid (PA) was purchased from 
Lipid Products Ltd. (Nutfield). 
Liposomes or lipid vesicles were prepared by 
sonication and checked by electron microscopy 
and oxidation index as in [14]. The preparations 
contained 1.5 mg lipid mixture (PC/PA, 9: 1, 
w/w)/ml buffer A (10 mM phosphate (PH 7.3), 
100 mM NaCl, 0.1 mM EDTA) in the form of 
liposomes with diameters around 25 nm. 
Labeling was performed as follows: to 1 ml vesi- 
cle suspension as above, 10 ~1 of a 1 mM peptide 
solution and 3-10 x ld Bq of [1251]TID were add- 
ed. After 15 min incubation at 23’C, the samples 
were screened with a cuS0.1 filter (cut off at 
315 nm) and illuminated for 1 min with a IS0 W 
mercury lamp that produced 1.5 W at the target, 
thus ensuring complete photolysis of the TID [12]. 
Control experiments lacked either the peptide or 
the liposomes . 
Isolation of labeled peptides was effected by 
chromatography over a column (0.5 x 5 cm) of 
carboxymethyl cellulose (Whatman CM-52) after 
dis~ption of the liposomes with 0.05 ml Triton 
X-100. Initial washing with 300 ml I mM am- 
monium acetate (pH 5.5), removed practically all 
the by-products of photola~ling. The peptides 
were eluted with 1 M ~onium acetate at pH 7. 
Labeled enkephalin was esterified prior to 
chromatography to produce a net charge of 1 + ; 
identification of labeled peptides and chymotryptic 
hydrolysis or Edman degradation were performed 
as detailed in [ 141. 
The mean radioactivity in cpm of the peptide 
peak fractions of 2-5 independent labeling ex- 
periments, after deduction of the blank values 
from controls without peptide, was regarded as the 
labeling rate. 
3. RESULTS AND DISCUSSION 
[1251]TID partitions strongly in favor of the 
hydrophobic layers of lipid membranes [12] and 
into hydrophobic pockets of peptide aggregates 
i7,11,15]. The photolabeling of peptides with 
[‘251]TID in the presence of liposomes can be used 
to estimate the contribution of hydrophobic 
peptide-membrane interactions in the adsorption 
of peptides to liposomes and to distinguish them 
from electrostatic interactions. This has been 
demonstrat~‘for ACTH peptides, dioxin, and 
enkephalins by using a combination of liposome- 
mediated labeling’with [‘2sI]TID in the presence of 
liposomes with different head groups, infrared at- 
tenuated total reflection spectroscopy, and 
equilibrium dialysis [7,10,11,14,15]. 
Table 1 lists the primary structures of ACTH 
and opioid peptides, and their liposome-mediated 
labeling rates. The latter are a measure of 
hydrophobic peptide-membrane interactions. 
ACTHr-24 is strongly labeled through its message 
sequence, as has been demonstrated by spec- 
troscopy [7,10] and by chymotr~tic and Edman 
degradation [7,11,15]. ACTH7-2.4 and 
dynorphinr -$3 are also labeled in their message 
segments [7,11,14]. ACTHr-10 is not adsorbed to 
lipid membranes, and ACTHri-~4 is elec- 
trostatically adsorbed, but only to the membrane 
surface [7,10,11,15], resulting in a low liposome- 
mediated labeling rate in both cases. Leu- 
enkephalin shows a low rate of labeling with 
PC/PA (9 : 1, w/w) vesicles [7,11,14] and @- 
endorphin was not yet investigated. 
A comparison of the ~~sorne-rne~at~ labeling 
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Table 1 
Primary structure and liposome-mediated labeling of selected peptides with [‘251]TID 
July 1983 
Peptide Amino acid sequence PC/PA (9 : 1, w/w) 
liposome-mediated 
Message Address labeling rates 
1 ACTHr-24 + SYSM@HF$WG - $PVGl$#PVl$VYP - 10000 
2 ACTHs-24 + EHFI$WG - ~PVG~~~~P~YYP - 7000 
3 ACTH,-24 + FRWG - ~PVG~~~P~VYP - 9300 
4 ACTHlr-24 + I$PVGKKRRPVKVYP - 2700 
5 ACTHr-13amide + SYSMfiHF$WG - I$PVnh$’ 5200 
6 (Y-MSH acSYSMEHFI$WG - KPVnh2a’b 4000 
7 ACTHr-lo + SYSMEHFRWG +++ + + 3000 
8 Dynorphinr-13 + YGGF - LRRIRPKLK- 1000OC 
9 Leuenkephalin +YGGF - L-d 3000’ 
10 Dynorphin message +YGGF 15ooC 
11 &Endorphin + YGGF - MTS~KSQTPLVTLFKNAII- 
KNAYKKGE - n.d. 
a Lower case letters are used for symbols other than those for amino acids (ac, acetyl; nhz, amide) 
b In tu-MSH, KPV - nh2 is an additional message, not an address 111 
’ Recognized as ~~sorne-rne~at~ labeling rate by comp~ison of head-group specificities I141 
d Message-address ubdivision in analogy to 8 
n.d., not determined 
rates of ACTH peptides with two of their 
biological activities, steroidogenesis and inhibition 
of a synaptosomal protein kinase (values taken 
from [ 1,2]) revealed remarkable correlations 
(fig.l,2). It thus appeared likely that hydrophobic 
interactions of these peptides with the lipid phase 
of target cells, and the observed specific conforma- 
Labding rate kpm) 
Fig.1. Correlation between in vitro steroidogenic and 
antagonistic potency and vesicle-mediated labeling rate 
of co~icotropin-related peptides. 
tional transitions and topological arrangements in- 
duced in the peptides by the anisotropy of the 
membrane surroundings 17,101 may indeed be 
biologically significant. 
The strong antagonism of ACTH,-24 compared 
5000 toooo cpm 
Fig.2. Correlation between vesicle-mediated labeling 
rate and 070 inhibition of a synaptosomal protein kinase 
[2]. Labeling of ACTHs-24 is compared with the activity 
of ACTH5_rs, assuming similar potency of the two 
peptides. 
14 
Volume 158, number 1 FEBS LETTERS July 1983 
to ACTHii-24 (fig.1) was consistent with the 
observation that the message attached to the ad- 
dress contributes considerable hydrophobic bin- 
ding force [IS] but, in ACTH,-~4, lacks elements 
necessary for triggering receptors [ 11. The very low 
biological activity of ACTHi- (the message lack- 
ing the address) correlates well with its inability to 
establish hydrophobic contacts with the mem- 
brane. Thus, artificial membranes appeared to be 
sensitive probes for the amphiphilic and conforma- 
tional requirements necessary for biologic activity. 
Amphiphilicity is a characteristic of the strong 
agonists and antagonist of table 1: ACTHi-~4, 
ACTHs-U, ACTH,-24, dynorphini-is [16], and& 
endorphin [17]. It is caused by the separation into 
a hydrophobic message segment and a hydrophilic 
address segment, a feature common to all of these 
peptides. ACTHi- and dynorphini_i3 insert 
their messages into the membrane hydrophobic 
layers [7,11,14,15], their addresses remain on the 
surface of the membranes. The behaviour of ,& 
endorphin is not known, although it is adsorbed to 
lipid micelles [ 181. 
The adsorption of ACTHi- to lipid mem- 
branes results in conformational transitions caused 
by the anisotropic surroundings: the message 
assumes a helical structure entering the membrane 
perpendicularly, and the address assumes an ir- 
regular, extended conformation on the membrane 
surface with the peptide bond planes oriented 
perpendicularly to the membrane plane [lo]. We 
have not yet investigated the secondary structure 
of dynorphini-13, but it was reported that the 
message assumes no regular conformation and that 
the address probably is a helix with its axis parallel 
to the membrane surface [ 191. A detailed study of 
fl-endorphin revealed that an amphiphilic helix in 
the C-terminal region (residues 13-29) is an impor- 
tant structural determinant for the activity, pro- 
bably serving to anchor the peptide to membrane 
surfaces, and that residues 6-12 constitute a flexi- 
ble hinge between the membrane anchor ’ 13-29 
and the message l-5 [20]. Such hinge regions had 
been postulated earlier for ACTH peptides on 
purely pharmacological grounds; e.g., Gly”, Pro” 
HI. 
Dynorphin and /3-endorphin are known to be 
much more potent than the enkephalins in opiate 
assays, and enkephalin is more potent than the 
dynorphin message segment, YGGF [ 161. Thus, as 
shown in table 1, addition of the enkephalin ‘ad- 
dress’, L, to this message, or the addition of the 
dynorphin or ,&endorphin addresses increases both 
the opiate potency and the hydrophobic interac- 
tion with lipid membranes. 
It has been demonstrated that ACTH peptides 
exhibit opiate peptide cross reactivity since, for ex- 
ample, a-MSH causes similar effects as ,8- 
endorphin when injected into the periaqueductal 
gray matter of rats [4], and ACTH peptides inhibit 
electrically evoked contractions of the mouse vas 
deferens in a naloxone-reversible manner [3]. 
ACTHi- was about 45times less active than ,&- 
endorphin in the displacement of labeled 
dihydromorphine or naloxone from rat brain 
membrane preparations [5], but about 
30-200-times more active than peptides derived 
from the message segment, residues l-10, of 
ACTH. 
Like ACTHi-24, ACTHi- consists of the 
hydrophobic message and a hydrophilic address 
[I]. Thus, as in the enkephalin-,&endorphin-- 
dynorphin series, amphiphilic structure and 
hydrophobic interactions enhance the opiate-like 
binding characteristics of ACTH peptides. 
In 1976, we proposed a helical model of the 
message segment of ACTH to account for its ac- 
tion on different types of receptor: steroidogenic, 
melanotropic, and behavioural (central nervous 
system) [11. This model has been applied to explain 
the ACTH-&endorphin cross reactivity [5]. It 
now can be refined to include the influence of the 
address: The address is necessary to allow the 
message to penetrate into the membrane and to 
assume a helical structure [7,10,14]. 
Our findings also lend support to a recently 
developed model of the ,&endorphin receptor 
(review [21]). According to this hypothesis, the ,& 
endorphin receptor is a lipoprotein complex com- 
posed of protein, with 6 and x opiate receptor 
specificity, and lipids (cerebroside sulfate), with p 
specificity. In our model, the binding of the 
agonists to the lipid phase is strengthened by their 
amphiphilicity. In this process, the messages 
assume specific secondary structures and 
topological arrangements within the membrane, 
perhaps facilitating favorable contacts with the 
protein parts of the receptor. Furthermore, we 
have found that, in contrast to enkephalins with a 
free carboxy group and, hence, a preference for S 
15 
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receptors, enkephalin amides with a preference for 
p receptors interact much more strongly with 
cerebroside sulfate liposomes than with liposomes 
composed of PC, PA, or phosphatidylserine 
[7,14]. This behaviour is similar to that of mor- 
phine [22,23]. 
Thus, our results indicate that the lipid phase of 
target cell membranes may exert significant in- 
fluences on biological activity by being parts of 
receptors and by capturing agonists from the sur- 
rounding fluid and inducing conformations and 
topological arrangements of the agonist that are 
favorable for receptor interaction. 
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